Incyte | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Acadia Pharmaceuticals USD 765.24M 32.44M 2025-03
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amgen USD 6.21B 330M 2025-03
Biogen USD 16.98B 262.7M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Exelixis USD 2.13B 113.18M 2025-04
Gilead Sciences USD 19.33B 856M 2024-12
Incyte USD 3.67B 219.94M 2025-03
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
MacroGenics USD 116.06M 4.01M 2024-12
Merck USD 48.34B 2.02B 2025-03
Moderna USD 10.07B 835M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 605M 2024-12
Novartis USD 44.05B 729M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
PTC Therapeutics USD -185760000 912.31M 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Sarepta Therapeutics USD 1.14B 385.02M 2025-03
Ultragenyx Pharmaceutical USD 144.25M 111.05M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Incyte Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.